Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lastres-Becker

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Drug Targets. CNS and Neurological Disorders|October 8, 2003
The endocannabinoid system and Huntington's diseaseI Lastres-Becker, R De Miguel, J J Fernández-Ruiz
Free Radical Biology & Medicine|April 18, 2026
TARGETING PYROPTOSIS IN TAUOPATHIES: A REDOX-DRIVEN AXIS OF NEUROINFLAMMATION AND NEURODEGENERATIONE Alonso-López, I Silva-Llanes, E Díez-Tejedor, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
Endocannabinoids and basal ganglia functionalityJ Fernández-Ruiz, I Lastres-Becker, A Cabranes, et al.
Physiological Research|January 1, 1997
2'(3')-O-[N- [2- [3- [5-fluoresceinyl] thioureido] ethyl] carbamoyl] adenosine 5'-triphosphate and its Cr(H2O)4 and Co(NH3)4 complex derivatives are new fluorescent tools for labelling ATP binding sites of Na+/K+-ATPaseH Linnertz, I Lastres Becker, R Krumscheid, et al.
Cellular and Molecular Neurobiology|August 7, 2019
Cannabinoid CB<sub>2</sub> Receptor Modulation by the Transcription Factor NRF2 is Specific in Microglial CellsM Galán-Ganga, R Del Río, N Jiménez-Moreno, et al.
Brain Research|February 28, 2002
Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's diseaseI Lastres-Becker, F Berrendero, J J Lucas, et al.
Neuroreport|July 12, 2001
Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's diseaseI Lastres-Becker, F Fezza, M Cebeira, et al.
Journal of Medicinal Chemistry|December 14, 2001
Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitorsM L López-Rodríguez, A Viso, S Ortega-Gutiérrez, et al.
European Journal of Pharmacology|June 16, 2001
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologuesV Di Marzo, I Lastres-Becker, T Bisogno, et al.
Neurogenetics|February 28, 2015
Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rateM Fittschen, I Lastres-Becker, M V Halbach, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Drug Targets. CNS and Neurological Disorders|October 8, 2003
The endocannabinoid system and Huntington's diseaseI Lastres-Becker, R De Miguel, J J Fernández-Ruiz
Free Radical Biology & Medicine|April 18, 2026
TARGETING PYROPTOSIS IN TAUOPATHIES: A REDOX-DRIVEN AXIS OF NEUROINFLAMMATION AND NEURODEGENERATIONE Alonso-López, I Silva-Llanes, E Díez-Tejedor, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
Endocannabinoids and basal ganglia functionalityJ Fernández-Ruiz, I Lastres-Becker, A Cabranes, et al.
Physiological Research|January 1, 1997
2'(3')-O-[N- [2- [3- [5-fluoresceinyl] thioureido] ethyl] carbamoyl] adenosine 5'-triphosphate and its Cr(H2O)4 and Co(NH3)4 complex derivatives are new fluorescent tools for labelling ATP binding sites of Na+/K+-ATPaseH Linnertz, I Lastres Becker, R Krumscheid, et al.
Cellular and Molecular Neurobiology|August 7, 2019
Cannabinoid CB<sub>2</sub> Receptor Modulation by the Transcription Factor NRF2 is Specific in Microglial CellsM Galán-Ganga, R Del Río, N Jiménez-Moreno, et al.
Brain Research|February 28, 2002
Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's diseaseI Lastres-Becker, F Berrendero, J J Lucas, et al.
Neuroreport|July 12, 2001
Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's diseaseI Lastres-Becker, F Fezza, M Cebeira, et al.
Journal of Medicinal Chemistry|December 14, 2001
Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitorsM L López-Rodríguez, A Viso, S Ortega-Gutiérrez, et al.
European Journal of Pharmacology|June 16, 2001
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologuesV Di Marzo, I Lastres-Becker, T Bisogno, et al.
Neurogenetics|February 28, 2015
Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rateM Fittschen, I Lastres-Becker, M V Halbach, et al.
Pageof 2